FIELD: medicine, pharmaceutical industry.
SUBSTANCE: invention relates to production of solid pharmaceutical agents enhancing excretive kidney function useful in treatment of hypertension and chronic heart failure, accompanying with retention of sodium and water in organism. Claimed pelleted pharmaceutical composition comprises core, containing (mass %) inapamide 0.8-1.0; lactobiose 51-30; polyvinylpyrrolidone 1-3; microcrystalline cellulose 20-30; starch glycolate 3-10; magnesium stearate 0.1-1.04 and stomach soluble shell containing (mass %): oxypropylcellulose 25-40; vinylpyrrolidone-vinylacetate copolymer 25-40; titania 20-30; and talc 10-20. Method for production of such composition also is disclosed.
EFFECT: pelleted pharmaceutical composition of high active ingredient solubility without losses of tablet stability.
7 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL FORMULATION OF PROLONGED ACTION WITH DIURETIC, VASODILATATION AND HYPOTENSIVE ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2286150C1 |
MEDICINAL FORMULATION ELICITING NONSTEROID ANTI-INFLAMMATORY EFFECT AND METHOD FOR ITS MAKING | 2004 |
|
RU2261095C1 |
MEDICINAL FORMULATION POSSESSING ANTIBACTERIAL EFFECT AND METHOD FOR ITS MAKING | 2005 |
|
RU2281773C1 |
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
ANTIBACTERIAL DRUG AND A METHOD FOR MANUFACTURE THEREOF | 2002 |
|
RU2246946C2 |
MEDICINAL FORMULATION POSSESSING ANTI-VOMITING EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2268047C2 |
DIURETIC AND HYPOTENSIVE AGENT AS TABLET | 2001 |
|
RU2191572C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIMICROBIAL ACTION, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497501C1 |
Authors
Dates
2006-11-10—Published
2003-02-06—Filed